Clinical implications of expression of vascular endothelial growth factor in metastatic lesions of ovarian cancers

被引：0
|
作者：
J Fujimoto
H Sakaguchi
I Aoki
S Khatun
T Tamaya
机构：
[1] Gifu University School of Medicine,Department of Obstetrics and Gynecology
来源：
British Journal of Cancer | 2001年 / 85卷
关键词：
VEGF; metastatic lesion; patient prognosis; ovarian cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Vascular endothelial growth factor (VEGF) has been identified as an important factor for tumour angiogenesis, which is essential for the growth, invasion and metastasis of solid tumours. Significantly increased VEGF level from the primary tumour to the metastatic lesion of ovarian cancers was found in 8 of 30 cases. The 24-month survival rate of the patients with significantly increased VEGF level was extremely poor (0/8 = 0%) in comparison with that of patients with no change in the level (15/22 = 68%) from the primary tumour to the metastatic lesion. This indicates that VEGF may contribute to the advancement of metastatic lesions, and that VEGF level in metastatic lesions may be a prognostic indicator. © 2001 Cancer Research Campaign
引用
收藏
页码：313 / 316
页数：3
相关论文
共 50 条
  • [1] Clinical implications of expression of vascular endothelial growth factor in metastatic lesions of ovarian cancers
    Fujimoto, J
    Sakaguchi, H
    Aoki, I
    Khatun, S
    Tamaya, T
    BRITISH JOURNAL OF CANCER, 2001, 85 (03) : 313 - 316
  • [2] Biologic implications of the expression of vascular endothelial growth factor subtypes in ovarian carcinoma
    Fujimoto, J
    Sakaguchi, H
    Hirose, R
    Ichigo, S
    Tamaya, T
    CANCER, 1998, 83 (12) : 2528 - 2533
  • [3] Clinical implications of expression of ETS-1 related to angiogenesis in metastatic lesions of ovarian cancers
    Fujimoto, J
    Aoki, I
    Toyoki, H
    Khatun, S
    Sato, E
    Sakaguchi, H
    Tamaya, T
    ONCOLOGY, 2004, 66 (05) : 420 - 428
  • [4] Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers
    J Fujimoto
    H Toyoki
    E Sato
    H Sakaguchi
    T Tamaya
    British Journal of Cancer, 2004, 91 : 466 - 469
  • [5] Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers
    Fujimoto, J
    Toyoki, H
    Sato, E
    Sakaguchi, H
    Tamaya, T
    BRITISH JOURNAL OF CANCER, 2004, 91 (03) : 466 - 469
  • [6] Vascular endothelial growth factor polymorphisms and a synchronized examination of plasma and tissue expression in epithelial ovarian cancers
    Bhaskari, J.
    Premalata, C. S.
    Shilpa, V.
    Rahul, B.
    Pallavi, V. R.
    Ramesh, G.
    Krishnamoorthy, Lakshmi
    TUMOR BIOLOGY, 2016, 37 (01) : 1017 - 1023
  • [7] Enhanced expression of vascular endothelial growth factor in metastatic melanoma
    Salven, P
    Heikkila, P
    Joensuu, H
    BRITISH JOURNAL OF CANCER, 1997, 76 (07) : 930 - 934
  • [8] Enhanced expression of vascular endothelial growth factor in metastatic melanoma
    P Salven
    P Heikkilä
    H Joensuu
    British Journal of Cancer, 1997, 76 : 930 - 934
  • [9] Expression of vascular endothelial growth factor in human gallbladder lesions
    Yamamoto, S
    Fujii, K
    Kitadai, Y
    Yamamoto, S
    Tsuchida, A
    Kajiyama, G
    ONCOLOGY REPORTS, 1998, 5 (05) : 1065 - 1069
  • [10] Expression of Vascular Endothelial Growth Factor Receptors in Benign Vascular Lesions of the Orbit
    Atchison, Elizabeth A.
    Garrity, James A.
    Castillo, Francisco
    Engman, Steven J.
    Couch, Steven M.
    Salomao, Diva R.
    OPHTHALMOLOGY, 2016, 123 (01) : 209 - 213
12345